Superior Group's Strategic Pivot: Margins, Impairment, and a Rebound in Contact Centers

A Quarterly Juggling Act

Superior Group of Companies (SGC) delivered a headline-grabbing second quarter: revenue up 3%, EBITDA up 27%, and adjusted EPS of $0.21, more than double the prior year. Yet the quarter was anything but clean. Management candidly walked through a $2.6 million noncash trade name impairment in Healthcare Apparel, a similar inventory write-down, and a deliberate strategic shift in that segment's product assortment. The market rewarded the beat with a 90-day price gain of 17.4%, though the stock has since pulled back ~10% from its August 6 peak.

The core message from management is that SGC is managing through a choppy demand environment by leaning into its strongest segments and making tough but necessary portfolio decisions. As CEO Michael Benstock put it: “We are proud to have delivered a strong quarter with consolidated revenue up 3% year-over-year, a 160 basis point improvement in SG&A, EBITDA up 27% to $7.7 million and adjusted diluted EPS of $0.21, more than doubling the second quarter of 2025.” — Michael Benstock, Chief Executive Officer · 2026-08-04 That optimism, however, is tempered by guidance that holds at $572–$585 million in sales and $0.54–$0.66 in adjusted EPS, suggesting the back half is still uncertain.

Healthcare Apparel: A Deliberate Reset

The most notable strategic shift is in Healthcare Apparel, where revenue declined 4% and gross margin fell 260 basis points, driven by a noncash inventory write-down tied to a decision to narrow the product assortment. New segment leader Chris Hine, only three to four months into the role, is already rearchitecting the product line, focusing on “narrow and deeper” assortments. CFO Mike Koempel explained the rationale in response to an analyst question: “He's really started with the product and beginning to formulate what he thinks is the appropriate assortment architecture going forward... getting to what I would call a more focused assortment, so going, so to speak, narrow and deeper.” — Michael Koempel, President and Chief Financial Officer · 2026-08-04 This is a long-lead-time business, so the impact will take time. Management expects margin pressure to persist through the balance of 2026, with improvement only in 2027.

This deliberate pivot is reminiscent of prior commentary on dealing with uncertainty. On the Q1 2026 call, Benstock noted: “For the last 6 years, we've been operating in this crazy uncertain environment... maybe uncertainty is the new norm. And we think we're very, very good at operating during uncertain times better than a lot of our competition.” — Michael Benstock, Chief Executive Officer · 2026-05-04 The Healthcare Apparel move is a bet that focused assortment will ultimately drive better margins and working capital, even if it hurts near-term results.

Branded Products: Riding Existing Customer Growth

The star of the quarter was Branded Products, up 6% to $98 million, with gross margin expanding nearly a full point and EBITDA up 25%. Growth was driven entirely by existing customers — higher volumes on existing programs — while the pipeline also remains strong. Jake Himelstein, President of Branded Products, attributed margin gains to favorable customer mix and improved sourcing. He also emphasized that the company is “gaining share organically” and remains on the hunt for acquisitions that expand capabilities, citing the Guardian Products acquisition as a blueprint.

The margin improvement in this segment is structural, not cyclical. As Himelstein said, “We are not in a race to the bottom.” This is a key differentiator in a fragmented promotional merchandise market. With tariffs normalizing, tariff refund benefits are also starting to flow through — $1.8 million net in Healthcare Apparel alone — which helps support the bottom line without pricing pressure on customers.

Contact Centers: Stabilization and M&A Ambitions

Contact Centers revenue declined 4% year-over-year but improved sequentially for the second consecutive quarter. The segment's EBITDA actually rose, driven by SG&A leverage and a lapping of prior-year credit loss reserves. Management expects continued sequential improvement through the back half, with new customer wins converting from a “significantly larger pipeline.”

M&A remains a strategic priority, particularly for the Contact Center business. CEO Michael Benstock reiterated a timeframe: “Either we will have an acquisition done this year or we will find ourselves doing a start-up of a call center in the Philippines that will begin this year and begin to provide revenue next year.” — Michael Benstock, Chief Executive Officer · 2026-08-04 This sense of urgency echoes earlier commentary from March 2026, when he described the M&A environment as “a deck a day” and noted the company was “looking for a path” to a lower-cost geography. The Philippines is central to that plan.

Financial Resiliency and What's Next

Underlying the narrative is a balance sheet that is improving. SGC generated $18 million in operating cash flow in the first half of the year, with inventory down to ~$90 million from higher levels. CFO Koempel noted that inventory has opportunity to come down further, providing additional cash. The company also repurchased shares opportunistically, with ~$9 million remaining on its authorization.

The quarterly numbers also show why the market is paying attention: gross margin held at 37–38% despite mix shifts, and the margin pressure in Healthcare Apparel is largely due to restructuring charges rather than ongoing operations. Excluding the impairment, adjusted EPS of $0.21 more than doubled, suggesting the core earnings power of the company is improving.

That said, the guidance range for the full year implies a very back-half-weighted cadence, with Q3 and Q4 expected to do the heavy lifting. Management chose to hold guidance despite the Q2 beat, citing the transitions in Healthcare Apparel and the still-slow decision-making environment. As Koempel put it: “We're still obviously very optimistic about the business, and we'll certainly relook at guidance as we get through the third quarter.”

The charge does not affect the company's cash position or cash flow from operating activities.

For investors, the real question is whether the Healthcare Apparel reset pays off. The company is essentially taking a short-term hit to reshape its portfolio for higher-quality growth. With Branded Products firing on all cylinders, Contact Centers stabilizing, and a disciplined capital allocation approach, Superior Group is positioning itself as a leaner, more focused operator. The next two quarters will be telling—not just for guidance, but for whether the strategic bets start to show up in the numbers.